Citation Impact
Citing Papers
Antioxidant effects of resveratrol in the cardiovascular system
2016
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice
2020
Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases
2018
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Role of Antioxidants and Natural Products in Inflammation
2016 Standout
Sirt3 Ameliorates Oxidative Stress and Mitochondrial Dysfunction After Intracerebral Hemorrhage in Diabetic Rats
2018
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Interaction between microbiota and immunity in health and disease
2020 Standout
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
2016
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
2018
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials
2022
A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study
2018
Gut microbiota in human metabolic health and disease
2020 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling
2015
Gut Microbiota–Dependent Trimethylamine N -Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes
2018
Resveratrol, human health and winemaking perspectives
2017
Nutraceutical or Pharmacological Potential of Moringa oleifera Lam.
2018 Standout
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
2017
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Suppression of Inflammatory Responses by Dihydromyricetin, a Flavonoid from Ampelopsis grossedentata, via Inhibiting the Activation of NF-κB and MAPK Signaling Pathways
2015
Precision Nutrition and the Microbiome, Part I: Current State of the Science
2019
Cardiovascular Effects of Flavonoids
2018
Polyphenols and Human Health: The Role of Bioavailability
2021 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Li Ran being referenced
Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway
2017
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
2014
Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial
2015
Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial
2015